PRLD logo

PRLD CAPEX

Quarterly CAPEX

$63.00 K
NaN%

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

PRLD Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

25.88%
PRLD quarterly capital expenditures is higher than 25.88% of companies in Healthcare sector

High & Low

All-time High

$63.00 K
PRLD quarterly capital expenditures is currently at an all-time high

3-Year Low

$63.00 K
PRLD quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PRLD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
PRLD next earnings announcement is scheduled for Feb 14, 2025

OtherPRLDcash flowmetrics:

Quarterly FCF

-$27.36 M
PRLD quarterly free cash flow is -$27.36 million

Quarterly CFO

-$27.30 M
PRLD quarterly cash flow from operations is -$27.30 million

Quarterly CFI

$10.73 M
PRLD quarterly cash flow from investing activities is $10.73 million

Quarterly CFF

-$131.00 K
PRLD quarterly cash flow from financing activities is -$131.00 thousand

TTM CAPEX

$63.00 K
NaN%

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

PRLD TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.68%
PRLD TTM capital expenditures is higher than 8.68% of companies in Healthcare sector

High & Low

All-time High

$63.00 K
PRLD TTM capital expenditures is currently at an all-time high

3-Year Low

$63.00 K
PRLD TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PRLD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
PRLD next earnings announcement is scheduled for Feb 14, 2025

OtherPRLDcash flowmetrics:

TTM FCF

-$107.56 M
PRLD TTM free cash flow is -$107.56 million

TTM CFO

-$105.72 M
PRLD TTM cash flow from operations is -$105.72 million

TTM CFI

$75.81 M
PRLD TTM cash flow from investing activities is $75.81 million

TTM CFF

$25.15 M
PRLD TTM cash flow from financing activities is $25.15 million

PRLD CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

PRLD CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat highat low
5 y5-yearat highat lowat highat low
alltimeall timeat highat lowat highat low

Prelude Therapeutics Incorporated CAPEX History

DateAnnualQuarterlyTTM
DateAnnualQuarterlyTTM
Sep 2024
-
$63.00 K
$63.00 K

FAQ

  • What is Prelude Therapeutics Incorporated quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Prelude Therapeutics Incorporated?
  • What is Prelude Therapeutics Incorporated TTM capital expenditures?
  • What is the all time high TTM CAPEX for Prelude Therapeutics Incorporated?

What is Prelude Therapeutics Incorporated quarterly capital expenditures?

The current quarterly CAPEX of PRLD is $63.00 K

What is the all time high quarterly CAPEX for Prelude Therapeutics Incorporated?

Prelude Therapeutics Incorporated all-time high quarterly capital expenditures is $63.00 K

What is Prelude Therapeutics Incorporated TTM capital expenditures?

The current TTM CAPEX of PRLD is $63.00 K

What is the all time high TTM CAPEX for Prelude Therapeutics Incorporated?

Prelude Therapeutics Incorporated all-time high TTM capital expenditures is $63.00 K